View Mobile Friendly Conference List »

Setting new standards in information exchange for the pharmaceutical and biotech industry


Dpharm Europe Kicks Off Research and Confirms Silicon Valley Entrepreneur and Patient Advocate, Tatyana Kanzaveli

  • September 24, 2015

  • 15369960054_eb38a8140f_o (1)

    Silicon Valley Entrepreneur and Patient Advocate, Tatyana Kanzaveli

    We are excited to confirm Tatyana Kanzaveli to the DPharm Europe 2016 conference.  After Ms Kanzaveli was diagnosed with cancer and frustrated by the lack of medical research explaining why she developed the disease despite leading a healthy lifestyle, she turned her diagnosis into a healthcare start up. Founder of Open Health Network, Ms Kanzaveli was invited to be part of the White House’s first Demo Day event. Her company, Open Health Network is a smart mobile health platform that helps healthcare organizations, researchers, and patient advocate groups create cutting-edge mobile applications without coding. Her platform allows medical researchers to create apps for clinical trials, find participants and collect data.

    DPharm, originally launched five year’s ago in Boston serves as the annual definitive US event for innovators in the clinical trial space. The entire conference introduces novel and bold approaches to help attendees think differently about how we do clinical trials to benefit patients.

    In 2015, we launched Dpharm Europe to showcase and benchmark more global examples of innovation. The European event takes place February 9-10 at the St Pancras Renaissance Hotel in London. In the spirit of biomedical research investments in and around St Pancras/ Kings Cross, we are delighted to support the UK government’s effort in helping make this area the center of R&D innovation. On one side of the hotel, the brand new Francis Crick Institute is due to open in early 2016 and will house about 1,250 scientists from various disciplines across the globe. Down the street is the Wellcome Trust and Collection, which explores the connections between medicine, life and art in the past, present and future. Stay tuned as we report on the developments of the DPharm Europe agenda and speaking faculty. For more information, contact Jennifer Moran at